Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides
Jessica Elliott, Shalini Ahlawat, H. Miles Prince, Glen Kennedy, Jillian Wells, Gillian Huang, Jenny Collins, Peter Bardy, Carrie Van Der Weyden, David Ritchie, Amit Khot (2022). Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides. , 57(11), DOI: https://doi.org/10.1038/s41409-022-01787-3.
Letter151 days agoMycosis fungoides and Sézary syndrome: Australian clinical practice statement
Friyana Bhabha, Christopher McCormack, Jillian Wells, Belinda A. Campbell, Kate Newland, Stephen Lade, Odette Buelens, David Joske, Jake Shortt, Sally Mapp, Dejan Radeski, Mark Hertzberg, Amit Khot, Carrie Van Der Weyden, Christine Khoo, Eliza A. Hawkes, H. Miles Prince (2020). Mycosis fungoides and Sézary syndrome: Australian clinical practice statement. , 62(1), DOI: https://doi.org/10.1111/ajd.13467.
Article151 days agoSafety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study
Youn H. Kim, M. Bagot, Pier Luigi Zinzani, Madeleine Duvic, Stephen Morris, Ellen Kim, Amy Musiek, Pablo L. Ortiz‐Romero, Craig A. Elmets, Herbert Eradat, Nina Magnolo, Julia Scarisbrick, Stéphane Dalle, David C. Fisher, Michi M. Shinohara, Brian Poligone, Barbara Pro, Pietro Quaglino, Nishitha Reddy, Brigitte Dréno, Larisa J. Geskin, Ahmad Halwani, Amit Khot, M. Beylot‐Barry, Neil J. Korman, Frederick Lansigan, Sarah McCue Horwitz, Zanetta S. Lamar, Alison J. Moskowitz, Jillian Wells, Oleg E. Akilov, Dolores Caballero, Richard Cowan, Reinhard Dummer, Mary Jo Lechowicz, Francine M. Foss, Lars Iversen, Tomomitsu Miyagaki, Ryan Wilcox, Pierluigi Porcu, Maarten H. Vermeer, Sunil Abhyankar, Yukihiko Kato, Theresa R. Pacheco, Shigetoshi Sano, Basem M. William, Timothy S. Fenske, Noriko Fukuhara, Koji Habe, Toshihisa Hamada, Eiji Kiyohara, Bryone J. Kuss, Adam Lerner, Lawrence A. Mark, Javier Muñoz, Hiroyuki Okamoto, Christiane Querfeld, Jiro Uehara, Hisashi Uhara, Kentaro Yonekura, Auris Huen, Kensei Tobinai, Y. Tokura, Erin Boh, Jan P. Nicolay, Hidefumi Wada, Mollie Leoni, Takahiro Ito, Fiona Herr, Lubomir Sokol (2019). Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study. , 134(Supplement_1), DOI: https://doi.org/10.1182/blood-2019-122778.
Article151 days agoMogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, Alain H. Rook, Pierluigi Porcu, Sarah McCue Horwitz, Sean Whittaker, Y. Tokura, Maarten H. Vermeer, Pier Luigi Zinzani, Lubomir Sokol, Stephen Morris, Ellen J. Kim, Pablo L. Ortiz‐Romero, Herbert Eradat, Julia Scarisbrick, Athanasios Tsianakas, Craig A. Elmets, Stéphane Dalle, David C. Fisher, Ahmad Halwani, Brian Poligone, John P. Greer, Maria Teresa Fierro, Amit Khot, Alison J. Moskowitz, Amy Musiek, Andrei R. Shustov, Barbara Pro, Larisa J. Geskin, Karen M. Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S. Humphrey, Stacie Hudgens, Dmitri O. Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa R. Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura (2018). Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. , 19(9), DOI: https://doi.org/10.1016/s1470-2045(18)30379-6.
Article151 days ago